Treat patients with Alteco LPS Adsorber to remove endotoxin from the bloodstream. This can help achieve hemodynamic stabilization in the acute situation.
What treatment results to expect
After treatment, the following clinical benefits can be
expected as a positive effect of removing endotoxin from the bloodstream;
- Improved and stabilized hemodynamic parameters
- Reduced procalcitonin
- Reduced lactate
- Increase in lung oxygenating function
- Reduction or elimination of vasopressor support
- SOFA-score improvement
For best treatment results, the Alteco LPS Adsorber should be used as early as possible in hemoperfusion (HP), before acute kidney injury (AKI) escalates and the need for continuous renal replacement therapy (CRRT) arises.
The Alteco LPS Adsorber contains discs made of porous polyethylene (PE) covered in a tailor-made peptide. This synthetic peptide binds to lipid A; the toxic part of endotoxin. By adsorbing harmful levels of endotoxin from the patient’s bloodstream, the Alteco LPS Adsorber can break the chain of immune system over-reactions that can spiral into septic shock. This helps to stabilize the patient’s hemodynamic parameters in the acute situation.